127 related articles for article (PubMed ID: 36549982)
21. Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial.
Fonteyne V; Dirix P; Van Praet C; Berghen C; Albersen M; Junius S; Liefhooghe N; Noé L; De Meerleer G; Ost P; Villeirs G; Verbeke S; De Maeseneer D; Rammant E; Verghote F; Elhaseen E; De Man K; Decaestecker K
Eur Urol Focus; 2022 Sep; 8(5):1238-1245. PubMed ID: 34893458
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of prognostic nomogram based on log odds of positive lymph nodes for patients with gastric signet ring cell carcinoma.
Xu Z; Jing J; Ma G
Chin J Cancer Res; 2020 Dec; 32(6):778-793. PubMed ID: 33447000
[TBL] [Abstract][Full Text] [Related]
23. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
Front Oncol; 2022; 12():940601. PubMed ID: 36439411
[TBL] [Abstract][Full Text] [Related]
24. Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery.
Gao L; Lyu J; Luo X; Zhang D; Jiang G; Zhang X; Gao X; Zheng S; Wang X; Shen Y
BMC Cancer; 2021 Oct; 21(1):1149. PubMed ID: 34702197
[TBL] [Abstract][Full Text] [Related]
25. A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.
Di Trapani E; Sanchez-Salas R; Gandaglia G; Rocchini L; Moschini M; Lizee D; Carneiro A; Sivaraman A; Barret E; Rozet F; Galiano M; Bennamoun M; Colombo R; Suardi N; Briganti A; Montorsi F; Cathelineau X
World J Urol; 2016 Feb; 34(2):207-13. PubMed ID: 26198750
[TBL] [Abstract][Full Text] [Related]
26. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
[TBL] [Abstract][Full Text] [Related]
27. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
[TBL] [Abstract][Full Text] [Related]
28. Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.
Wang S; Yu Y; Xu W; Lv X; Zhang Y; Liu M
BMC Cancer; 2021 Aug; 21(1):653. PubMed ID: 34344326
[TBL] [Abstract][Full Text] [Related]
29. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
30. Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Font A; Domenech M; Buisan O; Lopez H; González A; Etxaniz O; Matas M; Elias X; Gomez M; Figols M; Horneros J; Pardo JC; Notario L; Ruiz de Porras V; Perez I; Areal J; Esteve A
World J Urol; 2022 Nov; 40(11):2627-2634. PubMed ID: 36107212
[TBL] [Abstract][Full Text] [Related]
31. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
[TBL] [Abstract][Full Text] [Related]
32. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.
Aziz A; May M; Burger M; Palisaar RJ; Trinh QD; Fritsche HM; Rink M; Chun F; Martini T; Bolenz C; Mayr R; Pycha A; Nuhn P; Stief C; Novotny V; Wirth M; Seitz C; Noldus J; Gilfrich C; Shariat SF; Brookman-May S; Bastian PJ; Denzinger S; Gierth M; Roghmann F;
Eur Urol; 2014 Jul; 66(1):156-63. PubMed ID: 24388438
[TBL] [Abstract][Full Text] [Related]
33. The Rate of Prostatic Involvement in Men Treated With Radical Cystectomy for Muscle Invasive Bladder Cancer.
Royal-Preyra B; Cury FL; Katib Y; Monsoor M; Brimo F; Kassouf W; Souhami L
Pract Radiat Oncol; 2023; 13(1):e68-e72. PubMed ID: 35901948
[TBL] [Abstract][Full Text] [Related]
34. Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
Necchi A; Pond GR; Moschini M; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Vaishampayan U; Theodore C; Sridhar SS; Rosenberg JE; Bellmunt J; Gallina A; Colombo R; Montorsi F; Briganti A; Galsky MD
Clin Genitourin Cancer; 2019 Feb; 17(1):7-14.e3. PubMed ID: 30292628
[TBL] [Abstract][Full Text] [Related]
35. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.
; Bochner BH; Kattan MW; Vora KC
J Clin Oncol; 2006 Aug; 24(24):3967-72. PubMed ID: 16864855
[TBL] [Abstract][Full Text] [Related]
36. A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery.
Jiang S; Yang F; Zhang L; Sang X; Lu X; Zheng Y; Xu Y
J Endocrinol Invest; 2022 Dec; 45(12):2341-2351. PubMed ID: 35908009
[TBL] [Abstract][Full Text] [Related]
37. A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery.
Jiang S; Zhang J; Zhang L; Xu Y; Zhao H; Sang X; Lu X
Sci Rep; 2022 Oct; 12(1):16466. PubMed ID: 36183006
[TBL] [Abstract][Full Text] [Related]
38. The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort.
Muilwijk T; Akand M; Soria F; Giordano A; Milenkovic U; Moris L; Gevaert T; Van Poppel H; Albersen M; Gontero P; Joniau S
BJU Int; 2020 Dec; 126(6):704-714. PubMed ID: 32640103
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
40. Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
Chen T; Zhan X; Chen X; Jiang M; Wan H; Fu B; Chen L
Front Oncol; 2022; 12():895413. PubMed ID: 35928878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]